Speaker Details

Andrew J. Kaufman, MD, FAAD

Andrew J. Kaufman, MD, FAAD

Clinical Professor, Keck School of Medicine of USC

BIOGRAPHY

Andrew J. Kaufman, M.D., remains in private practice in Thousand Oaks and Santa Barbara, California. Doctor Kaufman specializes primarily in Mohs micrographic surgery, facial reconstruction and dermatologic surgery. Doctor Kaufman attended University of California at Los Angeles School of Medicine, where he received his medical degree. He completed residencies in internal medicine at Cedars-Sinai Medical Center and dermatology at University of California at Los Angeles School of Medicine. He is board certified in internal medicine, dermatology and micrographic dermatologic surgery. Doctor Kaufman completed a fellowship in Mohs Micrographic Surgery and Dermatologic Surgery at the University of California at San Francisco School of Medicine. He was elected as Fellow of the American College of Physicians and is a Fellow of the American College of Mohs Surgery and American Society for Dermatologic Surgery. He continues to teach residents and medical students at the Keck School of Medicine of USC, where he is a Clinical Professor in the Department of Dermatology. Dr. Kaufman regularly lectures at international dermatology and plastic surgery meetings on Mohs surgery, reconstructive surgery and other facets of dermatologic surgery. He is a former member of the Board of Directors of the American College of Mohs Surgery. Currently, he is the author of over twenty-five scientific articles in the medical literature and four book chapters on topics in dermatologic surgery. He is co-editor of the second and third editions of Flaps and Grafts in Dermatologic Surgery and author of the textbook Practical Facial Reconstruction, Theory and Practice, first and second editions.

SESSIONS

S021 How Would You Reconstruct It
Mar 20, 2027 • 9:00 AM - 12:00 PM
S040 Pearls from the Masters of Dermatological Surgery
Mar 21, 2027 • 1:00 PM - 4:00 PM

DISCLOSURES

No financial relationships exist with ineligible companies.